Breast cancer Proteogenomics
41 – 50 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- Contribution to journal › Article
- 2019
-
Mark
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer
- Contribution to journal › Article
-
Mark
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
- Contribution to journal › Article
- 2018
-
Mark
High-throughput molecular techniques and personalized treatment for primary breast cancer
(2018)
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial
- Contribution to journal › Article
-
Mark
Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups
- Contribution to journal › Article
-
Mark
AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
- Contribution to conference › Abstract
- 2016
-
Mark
Cancer associated proteins in blood plasma : Determining normal variation
- Contribution to journal › Article
